Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma

@inproceedings{Bari2017TumoralMA,
  title={Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma},
  author={Omar Bari and Philip Randolph Cohen},
  booktitle={Cureus},
  year={2017}
}
Tumoral melanosis is a form of completely regressed melanoma that usually presents as darkly pigmented lesions suspicious for malignant melanoma. Histology reveals dense dermal and subcutaneous infiltration of melanophages. Pembrolizumab is an antibody directed against programmed death receptor-1 (PD1) and is frontline treatment for advanced melanoma. An 81-year-old man with metastatic melanoma treated with pembrolizumab who developed tumoral melanosis at previous sites of metastases is… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 10 references

The many faces of completely regressed malignant melanoma

  • RJ Barr
  • Pathology (Phila)
  • 1994
2 Excerpts

Similar Papers

Loading similar papers…